Epperly Michael W, Sacher Joshua R, Krainz Tanja, Zhang Xiaolin, Wipf Peter, Liang Mary, Fisher Renee, Li Song, Wang Hong, Greenberger Joel S
Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, U.S.A.
Department of Chemistry, University of Pittsburgh, Pittsburgh, PA, U.S.A.
In Vivo. 2017 Jan 2;31(1):39-43. doi: 10.21873/invivo.11022.
BACKGROUND/AIM: Mitochondrial-targeted gramicidin S (GS)-nitroxide, JP4-039, has been demonstrated to be a potent radiation mitigator, and safe over a wide dose range. In addition, JP4-039 has organ-specific effectiveness when locally applied.
We tested the effect of another GS-nitroxide, XJB-5-131, which has more effective mitochondrial localization, and compared these results to those for radiation mitigation against the hematopoietic syndrome, and two analogs of JP4-039, which have the same mitochondrial localization signal, but different chemical payloads: JRS527.084 contains a second nitroxide per molecule, and TK649.030 contains an ester group attached to the nitroxide.
The results demonstrate the superiority of JP4-039 as a systemic radiation mitigator.
Structure-activity relationships and bioassays demonstrate that JP4-039 is an optimized small-molecule radiation mitigator.
背景/目的:线粒体靶向短杆菌肽S(GS)-氮氧化物JP4-039已被证明是一种有效的辐射缓解剂,且在很宽的剂量范围内都安全。此外,JP4-039局部应用时具有器官特异性疗效。
我们测试了另一种GS-氮氧化物XJB-5-131的效果,其具有更有效的线粒体定位,并将这些结果与针对造血综合征的辐射缓解效果进行比较,还测试了JP4-039的两种类似物,它们具有相同的线粒体定位信号,但化学负载不同:JRS527.084每个分子含有第二个氮氧化物,TK649.030含有连接到氮氧化物上的酯基。
结果证明了JP4-039作为全身辐射缓解剂的优越性。
构效关系和生物测定表明JP4-039是一种优化的小分子辐射缓解剂。